The Rise in Robotic Atypical Segmentectomies
2 other identifiers
observational
600
1 country
1
Brief Summary
This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2020
CompletedFirst Submitted
Initial submission to the registry
November 19, 2020
CompletedFirst Posted
Study publicly available on registry
November 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
March 5, 2026
March 1, 2026
6.6 years
November 19, 2020
March 3, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Rate of change in robotic segmentectomies
Up to 2 years
Rate of typical and atypical segmentectomies
Up to 2 years
Differences in robotic versus other types of resections such as open and video-assisted thoracic surgery
Up to 2 years
Study Arms (1)
Observational (medical record review)
Patients' medical records are reviewed retrospectively.
Interventions
Eligibility Criteria
Patients who underwent a lung resection from 2004 to 2019
You may qualify if:
- Patients who underwent a lung resection from 2004 to 2019
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David C Rice
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2020
First Posted
November 25, 2020
Study Start
September 15, 2020
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
March 5, 2026
Record last verified: 2026-03